Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide is a dual agonist, hitting both GLP-1 and GIP receptors (two hormones)
Retatrutide (GLP-3): The Triple Agonist Peptide By Emerald Peptides Research Team | Reviewed for accuracy by our analytical chemistry team Published: November 20, 2025 Retatrutide (GLP-3): The Triple Agonist Peptide A Research Overview Retatrutide is a synthetic triple hormone receptor agonist that simultaneously targets the GLP-1, GIP, and glucagon receptors currently the most advanced compound in the incretin research class
L.WangS.HwangY.KimL
Intranasally administered IgG monoclonal antibodies were reported to clear non-infectious, Ebola virus-like particles within just 30 min (ref
The FDA is also reviewing nerandomilast for the treatment of PPF with a decision anticipated in early January 2026
